
The FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.
Our Nov. news & research list includes 2 successful genetic Alzheimer treatments in mouse models and a potential drug for Parkinson disease psychosis.
We present a selection of interesting neurology articles for the month of November in the following slides. See the slide legends for links to the article summaries.


